Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 435-437

  Howes, O D ^a   Rifkin, L ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antipsychotic; Diabetes mellitus; DKA; Olanzapine; Psychosis; Side effects

Indexed keywords

CHLORPROMAZINE; ISOPHANE INSULIN; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; DIABETIC COMA; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; PRIORITY JOURNAL; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC COMA; DIABETIC KETOACIDOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PSYCHOTIC DISORDERS;

EID: 6044239555     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800317     Document Type: Article

References (21)

1. Anonymous (2000) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 23 (Suppl 1): S4-S19
2. Anonymous (2002a) American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 25 (Suppl 1): S1-S147
3. Anonymous (2002b) American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 25 (Suppl 1): S1-S147
4. Davis J M, Chen N, Glick I D (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60: 553-564
5. Harris M I (1993) Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16: 642-652
6. Haupt D W, Newcomer J W (2001) Hyperglycemia and antipsychotic medications. J Clin Psychiatry 62 (Suppl 27): 15-26
7. Johnson R P, Al Taher M T, Madlock L E, Guo M, Nasdahl C S (2002) Increasing insulin dose for olanzapine-related diabetes. Am J Psychiatry 159: 150-151
8. Koro C E, Fedder D O, L'Italien G J, Weiss S S, Magder L S, Kreyenbuhl J, Revicki D A, Buchanan R W (3-8-2002) Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 325: 243
9. Maule S, Giannella R, Lanzio M, Villari V (1999) Diabetic ketoacidosis with clozapine treatment. Diabetes Nutr Metab 12: 187-188
10. Mir S, Taylor D (2001) Atypical antipsychotics and hyperglycaemia. Int Clin Psychopharmacol 16: 63-73
11. Muench J, Carey M (2001) Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. J Am Board Fam Pract 14: 278-282
12. Mukkerjee S, Decina P, Bocola V (1996) Diabetes mellitus in schizophrenic patients. Comp Psychiatry 37: 68-73
13. Newcomer J W, Haupt D W, Fucetola R, Melson A K, Schweiger J A, Cooper B P, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59: 337-345
14. Nicolai J, Smith S J, Keunen R W (2001) Simultaneous side effects of both clozapine and valproate. Intens Care Med 27: 943
15. Ragucci K R, Wells B J (2001) Olanzapine-induced diabetic ketoacidosis. Ann Pharmacother 35: 1556-1558
16. Ryan M C, Collins P, Thakore J H (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160: 284-289
17. Saydah S H, Loria C M, Eberhardt M S, Brancati F L (2001) Subclinical states of glucose intolerance and risk of death in the US. Diabetes Care 24: 447-453
18. Selva K A, Scott S M (2001) Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 138: 936-938
19. Straker D, Mendelowitz A, Karlin L (2002) Near fatal ketoacidosis with olanzapine treatment. Psychosomatics 43: 339-340
20. Tumbull D M, Bone A J, Tames F J, Wilson L, Baird J D, Sherratt H S (1985) The effect of valproate on blood metabolite concentrations in spontaneously diabetic, ketoacidotic, BB/E Wistar rats. Diabetes Res 2: 45-48
21. Wilson D R, D'Souza L, Sarkar N, Newton M, Hammond C (2003) New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res 59: 1-6